Scholarlink

<p>A reliable and sensitive RP-HPLC method was developed and validated for the accurate quantification of mesalamine in bulk and formulated pharmaceutical products. The analysis was carried out on a C18 column (150&#xa0;mm × 4.6&#xa0;mm, 5&#xa0;μm) using a mobile phase of methanol: water (60:40 v/v), with a flow rate of 0.8 mL/min, and UV detection at 230&#xa0;nm. Methanol: water (50:50 v/v) was used as the diluent. The method demonstrated excellent linearity across the concentration range of 10–50&#xa0;µg/mL (y = 173.53x – 2435.64, R² = 0.9992), high accuracy with recoveries between 99.05% and 99.25% (%RSD &lt; 0.32%), and outstanding precision with intra- and inter-day %RSD values below 1%. Robustness was confirmed under slight method variations (%RSD &lt; 2%), and LOD and LOQ were found to be 0.22&#xa0;µg/mL and 0.68&#xa0;µg/mL, respectively. Forced degradation studies under acidic, basic, oxidative, thermal, and photolytic stress confirmed the method’s specificity and stability-indicating capability. Assay of a commercial mesalamine tablet (Mesacol<sup>®</sup>, 800&#xa0;mg label claim) showed a recovery of 99.91%, validating the method’s applicability for routine quality control and regulatory compliance.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Design and validation of a robust stability-indicating reversed-phase HPLC method for quantification of mesalamine in formulated drug products

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月15日

查看全文
  • Ashish Sriram Mishra,
  • Manimaran Vasanthan

摘要

A reliable and sensitive RP-HPLC method was developed and validated for the accurate quantification of mesalamine in bulk and formulated pharmaceutical products. The analysis was carried out on a C18 column (150 mm × 4.6 mm, 5 μm) using a mobile phase of methanol: water (60:40 v/v), with a flow rate of 0.8 mL/min, and UV detection at 230 nm. Methanol: water (50:50 v/v) was used as the diluent. The method demonstrated excellent linearity across the concentration range of 10–50 µg/mL (y = 173.53x – 2435.64, R² = 0.9992), high accuracy with recoveries between 99.05% and 99.25% (%RSD < 0.32%), and outstanding precision with intra- and inter-day %RSD values below 1%. Robustness was confirmed under slight method variations (%RSD < 2%), and LOD and LOQ were found to be 0.22 µg/mL and 0.68 µg/mL, respectively. Forced degradation studies under acidic, basic, oxidative, thermal, and photolytic stress confirmed the method’s specificity and stability-indicating capability. Assay of a commercial mesalamine tablet (Mesacol®, 800 mg label claim) showed a recovery of 99.91%, validating the method’s applicability for routine quality control and regulatory compliance.

Graphical Abstract